Anthem to Pay $594M Share in Pending Blues Plan Antitrust Settlement
“Anthem is paying a substantial portion of Blues plans’ tentative antitrust settlement, which is estimated to be nearly $3 billion, executives said on a call with investors on Wednesday morning,” reports Paige Minemyer in Fierce Healthcare’s Payer.
“Anthem has penciled in $594 million for its contribution to the $2.7 billion settlement. The Blue Cross and Blue Shield Association reportedly agreed to the settlement in a lengthy class action suit late last month.”
“Anthem chief financial officer John Gallina called the settlement ‘pending’ during the earnings call, and said having a deal in the works ‘removes an uncertainty’ for the business around the ongoing litigation.”
